Daphna Joseph-Strauss
Papers
2
Total Citations
16
H-Index
2
About
Daphna Joseph-Strauss is a molecular biologist whose work has been instrumental in scaling up SARS-CoV-2 diagnostics during the pandemic. Her research centers on developing innovative, high-throughput viral detection methods that bypass traditional bottlenecks in testing. Her major contribution is the creation of **ApharSeq**, an extraction-free, early-pooling protocol that enables massively multiplexed SARS-CoV-2 detection. This approach, detailed in her 2020 paper (5 citations), eliminates the need for RNA extraction and allows hundreds of samples to be processed simultaneously, dramatically increasing testing capacity. Expanding on this, her 2021 paper (11 citations) introduced a refined method for early sample tagging and pooling, which not only detects the virus but simultaneously sequences variants—a critical capability for tracking viral evolution in real time. While her citation counts reflect the recent nature of this work, its impact is profound: these protocols have been adopted by clinical labs to streamline workflows, conserve reagents, and provide actionable genomic data. Joseph-Strauss’s work exemplifies how clever molecular engineering can directly address urgent public health needs, offering a blueprint for future pandemic preparedness.
Research Focus
Key Achievements
Top Papers
- 1
- 2